Lexicon Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Lexicon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Lexicon Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexicon Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $261k | 354k | 0.74 |
| 2024-09-30 | $189k | 120k | 1.57 |
| 2023-09-30 | $150k | 138k | 1.09 |
| 2023-06-30 | $335k | 138k | 2.43 |
| 2023-03-31 | $335k | 138k | 2.43 |
| 2022-12-31 | $227k | 119k | 1.91 |
| 2022-09-30 | $286k | 119k | 2.40 |
| 2022-06-30 | $327k | 176k | 1.86 |
| 2022-03-31 | $175k | 84k | 2.09 |
| 2021-12-31 | $331k | 84k | 3.94 |
| 2021-09-30 | $403k | 84k | 4.81 |
| 2021-06-30 | $351k | 76k | 4.59 |
| 2020-03-31 | $94k | 48k | 1.95 |
| 2019-12-31 | $4.6M | 1.1M | 4.15 |
| 2019-09-30 | $3.4M | 1.1M | 3.01 |
| 2019-06-30 | $7.0M | 1.1M | 6.29 |
| 2019-03-31 | $6.2M | 1.1M | 5.56 |
| 2018-12-31 | $20M | 2.9M | 6.64 |
| 2018-09-30 | $41M | 3.8M | 10.67 |
| 2018-06-30 | $48M | 4.0M | 12.00 |
| 2018-03-31 | $34M | 4.0M | 8.57 |
| 2017-12-31 | $41M | 4.2M | 9.88 |
| 2017-09-30 | $44M | 3.6M | 12.29 |
| 2017-06-30 | $63M | 3.8M | 16.45 |
| 2017-03-31 | $59M | 4.1M | 14.34 |
| 2016-12-31 | $57M | 4.1M | 13.83 |
| 2016-09-30 | $87M | 4.8M | 18.07 |
| 2016-06-30 | $94M | 6.6M | 14.35 |
| 2016-03-31 | $86M | 7.2M | 11.95 |
| 2015-12-31 | $113M | 8.5M | 13.31 |
| 2015-09-30 | $90M | 8.4M | 10.74 |
| 2015-06-30 | $52M | 6.5M | 8.05 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas